Glatt Group, headquartered in Germany, is a pioneering leader in the manufacturing and pharmaceutical industries, established in 1954. Its strength lies in providing comprehensive, integrated process solutions, capitalizing on advanced technology for powder synthesis and innovative particle design. This enables Glatt Group to offer solutions spanning the entire value chain, from initial particle production to final tablet formulation.
With a global presence through 16 subsidiaries, Glatt Group serves clients across the pharma, food/feed, and fine chemicals sectors. Its business segments include Glatt Pharmaceutical Services, focusing on complex pharmaceutical formulations, and Glatt Process Technology, which designs bespoke manufacturing systems for pharmaceuticals and other industries.
Despite its long-standing market leadership, the company has yet to secure recent investments, suggesting either a steady financial base or an area of opportunity for potential investors seeking long-term involvement in the life-sciences construction market.